Washington DC… In a victory for patients’ ability to afford prescription drugs, the Trump administration has delayed for two years implementation of a provision included in a proposed…
Washington DC… As consumers shop for health plans during open enrollment, the HIV+Hepatitis Policy Institute is reminding people, particularly those who depend on prescription drugs, to carefully review plan policies regarding copay assistance…
Washington DC…In a setback to patients’ ability to afford prescription drugs, the Trump administration has again attacked the use of drug manufacturer copay assistance for prescription…
Washington DC…Today, in a shock to patients, the Trump administration announced that health insurers do not have to count copay assistance from drug manufacturers towards…
Washington DC… Earlier this week the HIV + Hepatitis Policy Institute submitted comments to the HHS in strong opposition to a proposal that would dramatically increase the cost of prescription drugs for patients…